Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F1U85
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,455
Award facts
- Contract value 100% obligated
- $24,454.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 13, 2026, for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic medication used to treat inflammatory conditions. The contract is valued at $24,454.84 and carries a firm fixed price structure with no set-aside designation, indicating it was awarded through full and open competition. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the comprehensive vehicle for supplying pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a broad spectrum of medications across multiple therapeutic domains, including specialty drugs, vaccines, and medical devices. As a subsidiary of Cencora, Inc., the organization demonstrates consistent capability to fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and federal medical institutions through competitively awarded, firm fixed-price delivery orders.
Quick answers
Who was awarded contract SPE2DR26F1U85?
SPE2DR26F1U85 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1U85 worth?
The government has obligated $24,455 on SPE2DR26F1U85.
Is contract SPE2DR26F1U85 an order under another contract?
Yes. SPE2DR26F1U85 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U85 competed?
The extent of competition for SPE2DR26F1U85 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award